In vitro proliferative advantage of bone marrow cells with tetrasomy 8 in Ewing sarcoma

  • Luba Trakhtenbrot*
  • , Yoram Neumann
  • , Matilda Mandel
  • , Amos Toren
  • , Nelly Gipsh
  • , Esther Rosner
  • , Gideon Rechavi
  • , Frida Brok-Simoni
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

We describe a case of a 14.5-year-old boy with a clinically aggressive pelvic Ewing sarcoma. The tumor cells showed the presence of a typical t(11;22)(q24;q12) aberration and gains of chromosomes 8, 10, 14, and 21. To determine the size of the trisomy and tetrasomy 8 clones an interphase analysis by fluorescence in situ hybridization with a centromere-specific chromosome 8 probe was performed. Significant quantitative differences between metaphase and interphase data were obtained. It was shown that culturing of bone marrow cells leads to enrichment of tetrasomy 8 population that may be explained by the proliferative advantage of the tetrasomy 8 cells.

Original languageEnglish
Pages (from-to)176-178
Number of pages3
JournalCancer Genetics and Cytogenetics
Volume90
Issue number2
DOIs
StatePublished - Sep 1996

Funding

Funders
Israel Cancer Research Fund

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'In vitro proliferative advantage of bone marrow cells with tetrasomy 8 in Ewing sarcoma'. Together they form a unique fingerprint.

    Cite this